Hajjawi, 2013 - Google Patents
Human red blood cells-1Hajjawi, 2013
View PDF- Document ID
- 3299256909175772375
- Author
- Hajjawi O
- Publication year
- Publication venue
- American Journal Life Sciences
External Links
Snippet
Biochemists and cell biologists, who are interested in membranes, tend to regard the human red blood cell ambivalently. On one hand, red blood cells lack nuclei and the various intracellular organelles, yet that are highly specialized for a particular respiratory function …
- 241000282414 Homo sapiens 0 title abstract description 47
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ilesanmi | Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy | |
Vlahakes et al. | Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement | |
Helmkamp | Phospholipid transfer proteins: mechanism of action | |
US5948609A (en) | Oxygen-transporting albumin-based blood replacement composition and blood volume expander | |
JPH02501067A (en) | Ultra-pure semi-synthetic blood substitute | |
JPS6026092B2 (en) | Encapsulated hemoglobin and its production method | |
Chang | Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview | |
CN101489581A (en) | Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute | |
Portörő et al. | Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration | |
Nakao | New insights into regulation of erythrocyte shape | |
Lane et al. | Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S | |
US20080241233A1 (en) | Targeted delivery and expression of procoagulant hemostatic activity | |
Hugues et al. | Type III collagen and probably not type I collagen aggregates platelets | |
Hajjawi | Human red blood cells-1 | |
Sakai | Present situation of the development of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles) | |
Simoni et al. | Improved blood substitute: evaluation of its effects on human endothelial cells | |
Corry et al. | Increased Na/H antiport activity and abundance in uremic red blood cells | |
Golan et al. | Monopalmitoylphosphatidylcholine incorporation into human erythrocyte ghost membranes causes protein and lipid immobilization and cholesterol depletion | |
Scatena et al. | O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier | |
JPS6022683B2 (en) | How to improve the oxygen release properties of red blood cells | |
Davis et al. | Artificial red cells with crosslinked hemoglobin membranes | |
KRISHNA et al. | A review on artificial blood: a source we need | |
Nishiguchi et al. | Requirement of cytoplasmic components for lidocaine-induced shape change in human erythrocytes | |
Van der Heul et al. | In vitro and in vivo studies of iron delivery by human monoferric transferrins | |
Hajjawi | Human red blood cells-2 |